Non-alcoholic fatty liver disease

Claudia Della Corte, Daniela Liccardo, Antonella Mosca, Andrea Vania, Valerio Nobili

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Non-alcoholic fatty liver disease is rapidly becoming one of most common liver diseases in the paediatric population in industrialized countries due to the growing prevalence of obesity and overweight. Paediatric NAFLD is typically of primary origin and it is strongly associated with several features of the metabolic syndrome. The mainstay of NAFLD therapy is represented by lifestyle interventions on obesogenic environment and sedentary lifestyle, which aim to improve obesity, hepatic changes and quality of life as well. Unfortunately, this goal is very difficult to be achieved and pharmacological approaches have become necessary. Although in fairly recent years, many pharmacological agents, on the basis of pathogenetic mechanism of the disease, have been attempted, to date guidelines for the management of fatty liver are still lacking. Establishing effective therapeutic strategies to treat the disease represents the challenge for paediatric hepatologists in the near future. In this article, we briefly review the current knowledge and ideas concerning paediatric non-alcoholic fatty liver disease.

Original languageEnglish
Pages (from-to)529-534
Number of pages6
JournalPaediatrics and Child Health (United Kingdom)
Volume23
Issue number12
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Pediatrics
Obesity
Pharmacology
Sedentary Lifestyle
Fatty Liver
Developed Countries
Life Style
Liver Diseases
Quality of Life
Guidelines
Non-alcoholic Fatty Liver Disease
Liver
Therapeutics
Population
Gastroenterologists

Keywords

  • Children
  • Fatty liver
  • NAFLD
  • NASH

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Non-alcoholic fatty liver disease. / Della Corte, Claudia; Liccardo, Daniela; Mosca, Antonella; Vania, Andrea; Nobili, Valerio.

In: Paediatrics and Child Health (United Kingdom), Vol. 23, No. 12, 12.2013, p. 529-534.

Research output: Contribution to journalArticle

Della Corte, Claudia ; Liccardo, Daniela ; Mosca, Antonella ; Vania, Andrea ; Nobili, Valerio. / Non-alcoholic fatty liver disease. In: Paediatrics and Child Health (United Kingdom). 2013 ; Vol. 23, No. 12. pp. 529-534.
@article{6e468e7c848b440ab8ed06e7dd7c9a12,
title = "Non-alcoholic fatty liver disease",
abstract = "Non-alcoholic fatty liver disease is rapidly becoming one of most common liver diseases in the paediatric population in industrialized countries due to the growing prevalence of obesity and overweight. Paediatric NAFLD is typically of primary origin and it is strongly associated with several features of the metabolic syndrome. The mainstay of NAFLD therapy is represented by lifestyle interventions on obesogenic environment and sedentary lifestyle, which aim to improve obesity, hepatic changes and quality of life as well. Unfortunately, this goal is very difficult to be achieved and pharmacological approaches have become necessary. Although in fairly recent years, many pharmacological agents, on the basis of pathogenetic mechanism of the disease, have been attempted, to date guidelines for the management of fatty liver are still lacking. Establishing effective therapeutic strategies to treat the disease represents the challenge for paediatric hepatologists in the near future. In this article, we briefly review the current knowledge and ideas concerning paediatric non-alcoholic fatty liver disease.",
keywords = "Children, Fatty liver, NAFLD, NASH",
author = "{Della Corte}, Claudia and Daniela Liccardo and Antonella Mosca and Andrea Vania and Valerio Nobili",
year = "2013",
month = "12",
doi = "10.1016/j.paed.2013.08.003",
language = "English",
volume = "23",
pages = "529--534",
journal = "Paediatrics and Child Health (United Kingdom)",
issn = "1751-7222",
publisher = "Pulsus Group Inc.",
number = "12",

}

TY - JOUR

T1 - Non-alcoholic fatty liver disease

AU - Della Corte, Claudia

AU - Liccardo, Daniela

AU - Mosca, Antonella

AU - Vania, Andrea

AU - Nobili, Valerio

PY - 2013/12

Y1 - 2013/12

N2 - Non-alcoholic fatty liver disease is rapidly becoming one of most common liver diseases in the paediatric population in industrialized countries due to the growing prevalence of obesity and overweight. Paediatric NAFLD is typically of primary origin and it is strongly associated with several features of the metabolic syndrome. The mainstay of NAFLD therapy is represented by lifestyle interventions on obesogenic environment and sedentary lifestyle, which aim to improve obesity, hepatic changes and quality of life as well. Unfortunately, this goal is very difficult to be achieved and pharmacological approaches have become necessary. Although in fairly recent years, many pharmacological agents, on the basis of pathogenetic mechanism of the disease, have been attempted, to date guidelines for the management of fatty liver are still lacking. Establishing effective therapeutic strategies to treat the disease represents the challenge for paediatric hepatologists in the near future. In this article, we briefly review the current knowledge and ideas concerning paediatric non-alcoholic fatty liver disease.

AB - Non-alcoholic fatty liver disease is rapidly becoming one of most common liver diseases in the paediatric population in industrialized countries due to the growing prevalence of obesity and overweight. Paediatric NAFLD is typically of primary origin and it is strongly associated with several features of the metabolic syndrome. The mainstay of NAFLD therapy is represented by lifestyle interventions on obesogenic environment and sedentary lifestyle, which aim to improve obesity, hepatic changes and quality of life as well. Unfortunately, this goal is very difficult to be achieved and pharmacological approaches have become necessary. Although in fairly recent years, many pharmacological agents, on the basis of pathogenetic mechanism of the disease, have been attempted, to date guidelines for the management of fatty liver are still lacking. Establishing effective therapeutic strategies to treat the disease represents the challenge for paediatric hepatologists in the near future. In this article, we briefly review the current knowledge and ideas concerning paediatric non-alcoholic fatty liver disease.

KW - Children

KW - Fatty liver

KW - NAFLD

KW - NASH

UR - http://www.scopus.com/inward/record.url?scp=84888430602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888430602&partnerID=8YFLogxK

U2 - 10.1016/j.paed.2013.08.003

DO - 10.1016/j.paed.2013.08.003

M3 - Article

AN - SCOPUS:84888430602

VL - 23

SP - 529

EP - 534

JO - Paediatrics and Child Health (United Kingdom)

JF - Paediatrics and Child Health (United Kingdom)

SN - 1751-7222

IS - 12

ER -